Harnessing the Power of Targeted RNA Therapies for Cancer Treatment and Immunomodulation
Received Date: Sep 30, 2023 / Published Date: Oct 31, 2023
Abstract
Targeted RNA therapies have emerged as a promising frontier in the quest for more effective and personalized approaches to cancer treatment and immunomodulation. This article explores the potential of RNA-based therapies in both contexts, highlighting their precision and versatility. Small interfering RNA (siRNA) and microRNA (miRNA) therapies can selectively silence or regulate genes associated with cancer, while messenger RNA (mRNA) vaccines hold promise for training the immune system to combat malignancies. In the realm of immunomodulation, RNA-based strategies like CAR-T cell therapy and immune checkpoint inhibitors are revolutionizing cancer care. Challenges in delivery and off-target effects persist, but ongoing research and innovation are paving the way for a brighter future where RNA therapies become integral components of comprehensive cancer treatment.
Citation: Yu Z (2023) Harnessing the Power of Targeted RNA Therapies for CancerTreatment and Immunomodulation. J Pharmacokinet Exp Ther 7: 203. Doi: 10.4172/jpet.1000203
Copyright: © 2023 Yu Z. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
黑料网 Journals
Article Tools
Article Usage
- Total views: 571
- [From(publication date): 0-2023 - Nov 23, 2024]
- Breakdown by view type
- HTML page views: 491
- PDF downloads: 80
